US › Healthcare

Myomo Inc (MYO)

US · Healthcare · Medical Devices

$1.33+3.10%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$11.7M

Revenue YoY

+21.3%

Net profit

$-4.0M

EPS

$-0.07

EPS estimate

$-0.10

Net margin

-34.4%

EPS came in at -0.07 against a street estimate of -0.10 — a beat of 30.0%.

Key statistics

Market cap

$51.1M

Forward P/E

0.0

P/B

8.43

Book value

$0.15

EPS (TTM)

$-0.35

52-week high

$1.89

52-week low

$0.60

50-day MA

$1.29

200-day MA

$1.01

Beta

1.50

Analyst view

Analysts rate Myomo Inc a strong buy (5 buy, 0 hold, 0 sell out of 5) with an average price target of $4.64.

Shareholding

Insiders

9.36%

Institutions

37.88%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Myomo Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.